VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. [electronic resource]
Producer: 20130708Description: 3588-94 p. digitalISSN:- 1460-2385
- Aged
- Bone Density Conservation Agents -- therapeutic use
- Bone Diseases -- complications
- Calcification, Physiologic -- drug effects
- Ergocalciferols -- therapeutic use
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Health Surveys
- Humans
- Kidney Failure, Chronic -- etiology
- Male
- Middle Aged
- Parathyroid Hormone -- blood
- Prognosis
- Prospective Studies
- Receptors, Calcitriol -- metabolism
- Renal Dialysis -- mortality
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.